A new rat model links two contemporary theories in irritable bowel syndrome

Digestive Diseases and Sciences

Volumn 53, Issue 4, 2008, Pages 982-989

  Pimentel, Mark ^a   Chatterjee, Soumya ^a   Chang, Christopher ^b   Low, Kimberly ^a   Song, Yuli ^c   Liu, Chengxu ^c   Morales, Walter ^a   Ali, Lemeesa ^a   Lezcano, Sheila ^a   Conklin, Jeffery ^a   Finegold, Sydney ^c,d  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacterial overgrowth; Campylobacter jejuni; Post infectious IBS

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; CAMPYLOBACTER JEJUNI; INTESTINE INFECTION; IRRITABLE COLON; LYMPHOCYTE COUNT; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DEFECATION; DISEASE MODELS, ANIMAL; GASTROENTERITIS; IRRITABLE BOWEL SYNDROME; RATS; RATS, SPRAGUE-DAWLEY;

EID: 40749099050     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9977-z     Document Type: Article

References (24)

1. Neal KR, Hebden J, Spiller R (1997) Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis, and risk factors for development of the irritable bowel syndrome: postal survey of patients. Br Med J 314:779-782
2. Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR (2003) Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol 98:238-241
3. Barber R, Blakey A (1997) Prevalence of gastrointestinal symptoms after bacterial gastroenteritis: study did not include control group. Br Med J 314:1903
4. Neal KR, Barker L, Spiller RC (2002) Prognosis in post-infectious irritable bowel syndrome: a six-year follow up study. Gut 51:410-413
5. Okhuysen PC, Jiang ZD, Carlin L et al. (2004) Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterology 99:1774-1778
6. Mearin F, Perez-Oliveras M, Perello A et al. (2005) Dyspepsia and irritable bowel syndrome after a Salmonella outbreak: one-year follow-up cohort study. Gastroenterology 129:98-104
7. Spiller RC, Jenkins D, Thornley JP et al. (2000) Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47:804-811
8. Dunlop SP, Jenkins D, Neal KR, Spiller RC (2003) Relative importance of enterochromaffin cell hyperplasia, anxiety and depression in post-infectious IBS. Gastroenterology 125:1651-1659
9. Zaidel O, Park S, van den Burg B, Kong Y, Lechago J, Stein T, Morgan M, Pimentel M (2004) Intraepithelial lymphocytes and enteroendocrine cells are not increased in general IBS subjects compared to controls. Neurogastroenterol Mot
10. Pimentel M, Chow EJ, Lin HC (2000) Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastro 95:3503-3506
11. Pimentel M, Chow EJ, Lin HC (2003) Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo controlled study. Am J Gastroenterol 98:412-419
12. Lupascu A, Gabrielli M, Lauritano EC et al. (2005) Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 22:1157-1160
13. Posserud I, Stotzer P-O, Bjornsson ES et al. (2007) Altered counts of small bowel bacteria in patients with irritable bowel syndrome (IBS). Gut 56:802-808
14. Sharara AI, Aoun E, Abdul-Baki H et al (2006) A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 101:326-333
15. Pimentel M, Park S, Mirocha J, Kane S, Kong Y (2006) The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome. A randomized trial. Ann Intern Med 145:557-563
16. Bercik P, Wang L, Verdu EF et al (2004) Visceral hyperalgesia and intestinal dysmotility in a mouse model of post-infective gut dysfunction. Gastroenterology 127:179-187
17. Vantrappen G, Janssens J, Hellemans J, Ghoos Y (1977) The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 59:1158-1166
18. Pimentel M, Soffer EE, Chow EJ, Lin HC (2002) Lower frequency of MMC is found in IBS subjects with abnormal breath test suggesting bacterial overgrowth. Dig Dis Sci 47:2639-2643
19. Nadkarni MA, Martin FE, Jacques NA, Hunter N (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148:257-266
20. King TS, Toskes PP (1979) Small intestinal bacterial overgrowth. Gastroenterol 76:1035-1055
21. Szurszewski JH (1969) A migrating electrical complex of canine small intestine. Am J Physiol 217:1757-1763
22. Neal KR, Hebden J, Spiller R (1997) Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Br Med J 314:779-782
23. Mish B, Ilyas AA, Koski CL et al. (1993) Serologic evidence of previous Campylobacter jejuni infection in patients with Guillain-Barré Syndrome. Ann Intern Med 118:947-953
24. Rees JH, Soudain SE, Gregson NA, Hughes RAC (1995) Campylobacter jejuni infection and Guillain-Barré Syndrome. N Engl J Med 18:137-164